Similarly, several studies have demonstrated that tumor cells have the ability to induce the conversion of the adipocytes located near the tumor invasive front into so-called cancer-associated adipocytes (CAAs), which exhibit loss of fatty acid-binding protein 4 (FABP4), a terminal adipocyte differentiation marker [32,33,34]. This evidence concerns the gene FABP4 and cancer.